BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3259042)

  • 1. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine.
    Hewitt CW; Black KS; Henson LE; Achauer BM; Nguyen JH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):272-8. PubMed ID: 3259042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
    Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
    Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors.
    Hewitt CW; Black KS; Dowdy SF; Gonzalez GA; Achauer BM; Martin DC; Furnas DW; Howard EB
    Transplantation; 1986 Jan; 41(1):39-43. PubMed ID: 2867627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of donor hematolymphoid cells after rat-limb composite grafting.
    Ajiki T; Takahashi M; Inoue S; Sakuma Y; Oyama S; Kaneko T; Hakamata Y; Murakami T; Kume A; Kariya Y; Hoshino Y; Kobayashi E
    Transplantation; 2003 Mar; 75(5):631-6. PubMed ID: 12640301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts.
    Brouha PC; Perez-Abadia G; Francois CG; Laurentin-Perez LA; Gorantla V; Vossen M; Tai C; Pidwell D; Anderson GL; Stadelmann WK; Hewitt CW; Kon M; Barker JH; Maldonado C
    Transpl Int; 2004 Aug; 17(7):341-50. PubMed ID: 15349719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs.
    Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
    J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allografts.
    Adamson LA; Huang WC; Breidenbach WC; Rahhal D; Xu H; Huang Y; Pidwell DJ; Wei FC; Tobin G; Ildstad ST
    Microsurgery; 2007; 27(7):630-6. PubMed ID: 17868137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
    Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
    Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts.
    Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T
    J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.